Teleflex - TFX Stock Forecast, Price & News

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last twelve months. There are currently 6 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" TFX shares.
View TFX analyst ratings or view top-rated stocks.

12 equities research analysts have issued 12-month price objectives for Teleflex's stock. Their TFX share price forecasts range from $210.00 to $400.00. On average, they expect the company's stock price to reach $279.62 in the next year. This suggests a possible upside of 15.8% from the stock's current price.
View analysts price targets for TFX or view top-rated stocks among Wall Street analysts.

Teleflex's stock was trading at $249.63 at the beginning of 2023. Since then, TFX stock has decreased by 3.3% and is now trading at $241.50.
View the best growth stocks for 2023 here.

Teleflex saw a drop in short interest during the month of January. As of January 15th, there was short interest totaling 982,800 shares, a drop of 17.4% from the December 31st total of 1,190,000 shares. Based on an average trading volume of 398,100 shares, the short-interest ratio is presently 2.5 days.
View Teleflex's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our TFX earnings forecast.

Teleflex Incorporated (NYSE:TFX) issued its quarterly earnings data on Thursday, October, 28th. The medical technology company reported $3.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.03 by $0.48. The medical technology company earned $700.25 million during the quarter, compared to analysts' expectations of $698.25 million. Teleflex had a net margin of 14.76% and a trailing twelve-month return on equity of 16.26%. The business's quarterly revenue was up 11.5% on a year-over-year basis. During the same period last year, the company posted $2.77 EPS.
Read the conference call transcript.

Teleflex announced a quarterly dividend on Thursday, October 27th. Stockholders of record on Tuesday, November 15th will be paid a dividend of $0.34 per share on Thursday, December 15th. This represents a $1.36 annualized dividend and a yield of 0.56%. The ex-dividend date of this dividend is Monday, November 14th.
Read our dividend analysis for TFX.

Teleflex (NYSE:TFX) pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.56%. The dividend payout ratio is 15.60%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, TFX will have a dividend payout ratio of 10.08% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for TFX.

Teleflex updated its FY 2022 earnings guidance on Thursday, November, 3rd. The company provided earnings per share guidance of $12.80-$13.20 for the period, compared to the consensus EPS estimate of $13.10. The company issued revenue guidance of $2.79 billion-$2.82 billion, compared to the consensus revenue estimate of $2.81 billion.

73 employees have rated Teleflex Chief Executive Officer Liam Kelly on Glassdoor.com. Liam Kelly has an approval rating of 86% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW), QUALCOMM (QCOM), Advanced Micro Devices (AMD), Salesforce (CRM) and Cisco Systems (CSCO).

Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."

Teleflex's stock is owned by a variety of retail and institutional investors. Top institutional investors include Allspring Global Investments Holdings LLC (1.71%), Ceredex Value Advisors LLC (0.79%), Villere ST Denis J & Co. LLC (0.42%), Boston Trust Walden Corp (0.31%), Sumitomo Mitsui Trust Holdings Inc. (0.28%) and AMI Asset Management Corp (0.25%). Insiders that own company stock include Andrew A Krakauer, Cameron P Hicks, James J Leyden, John Deren, Liam Kelly, Stephen K MD Klasko, Stephen K MD Klasko and Stuart A Randle.
View institutional ownership trends.

Shares of TFX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TFX stock can currently be purchased for approximately $241.50.

Teleflex (NYSE:TFX) has a market capitalization of $11.33 billion and generates $2.81 billion in revenue each year. The medical technology company earns $485.37 million in net income (profit) each year or $8.72 on an earnings per share basis.

The company employs 14,000 workers across the globe.

Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The official website for the company is www.teleflex.com. The medical technology company can be reached via phone at (610) 225-6800, via email at shareholder@broadridge.com, or via fax at 215-553-5402.